Natus Medical (BABY) Misses Q4 EPS by 6c, Guides FY Well Below Views

Natus Medical (NASDAQ: BABY) reported Q4 EPS of $0.43, $0.06 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $141 million versus the consensus estimate of $136.65 million.

GUIDANCE:

Natus Medical sees Q1 2019 EPS of $0.01-$0.08, versus the consensus of $0.31. Natus Medical sees Q1 2019 revenue of $111-115 million, versus the consensus of $131.3 million.

Natus Medical sees FY2019 EPS of $1.12-$1.49, versus the consensus of $1.72. Natus Medical sees FY2019 revenue of $490-510 million, versus the consensus of $541.61 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41